Review



rabbit polyclonal anti ephb2 primary antibody  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Boster Bio rabbit polyclonal anti ephb2 primary antibody
    Comparison of serum <t>EphB2</t> levels between NPC patients and the control group. Data are presented as mean ± SD.
    Rabbit Polyclonal Anti Ephb2 Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+ephb2+primary+antibody/Anti-Ephrin+type-B+receptor+2+EPHB2+Antibody/pmc12794068-103-10-15
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti ephb2 primary antibody - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma"

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma

    Journal: Translational Oncology

    doi: 10.1016/j.tranon.2025.102641

    Comparison of serum EphB2 levels between NPC patients and the control group. Data are presented as mean ± SD.
    Figure Legend Snippet: Comparison of serum EphB2 levels between NPC patients and the control group. Data are presented as mean ± SD.

    Techniques Used: Comparison, Control

    EphB2 protein expression in nasopharyngeal tissues. (A) Representative western blot images of EphB2 expression in control tissues (nasopharyngeal mucosal chronic inflammation) and NPC tissues stratified by clinical stage (I–II vs. III–IV), EBV status, and recurrence status ( n = 3 per subgroup). Approximate molecular weights: EphB2, 117 kDa; GAPDH, 36 kDa. (B) Quantitative analysis of EphB2 expression normalized to GAPDH. Data represent mean ± SD from six independent experiments. ** P < 0.01 by one-way ANOVA with Tukey’s post-hoc test.
    Figure Legend Snippet: EphB2 protein expression in nasopharyngeal tissues. (A) Representative western blot images of EphB2 expression in control tissues (nasopharyngeal mucosal chronic inflammation) and NPC tissues stratified by clinical stage (I–II vs. III–IV), EBV status, and recurrence status ( n = 3 per subgroup). Approximate molecular weights: EphB2, 117 kDa; GAPDH, 36 kDa. (B) Quantitative analysis of EphB2 expression normalized to GAPDH. Data represent mean ± SD from six independent experiments. ** P < 0.01 by one-way ANOVA with Tukey’s post-hoc test.

    Techniques Used: Expressing, Western Blot, Control

    Immunofluorescence analysis of EphB2 expression in nasopharyngeal tissues. A: Nasopharyngeal mucosal chronic inflammation tissues; B: EBV(-) NPC tissues; C: EBV(+) NPC tissues. EphB2 staining is shown in red; nuclei are counterstained with DAPI (blue). Original magnification: 400×.
    Figure Legend Snippet: Immunofluorescence analysis of EphB2 expression in nasopharyngeal tissues. A: Nasopharyngeal mucosal chronic inflammation tissues; B: EBV(-) NPC tissues; C: EBV(+) NPC tissues. EphB2 staining is shown in red; nuclei are counterstained with DAPI (blue). Original magnification: 400×.

    Techniques Used: Immunofluorescence, Expressing, Staining

    Disease-free survival analysis based on recurrence (A), EBV infection status (B), and serum EphB2 expression (C). In (C), patients were divided into EphB2-Low and EphB2-High groups using the median serum concentration (11.161 ng/mL) as the cutoff. Vertical ticks indicate censored data.
    Figure Legend Snippet: Disease-free survival analysis based on recurrence (A), EBV infection status (B), and serum EphB2 expression (C). In (C), patients were divided into EphB2-Low and EphB2-High groups using the median serum concentration (11.161 ng/mL) as the cutoff. Vertical ticks indicate censored data.

    Techniques Used: Infection, Expressing, Concentration Assay

    ROC curves evaluating the diagnostic performance of serum EphB2, EBV infection status, and their combination in discriminating NPC patients from controls.
    Figure Legend Snippet: ROC curves evaluating the diagnostic performance of serum EphB2, EBV infection status, and their combination in discriminating NPC patients from controls.

    Techniques Used: Diagnostic Assay, Infection

    Related Articles

    Incubation:

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma.
    Article Snippet: .. After deparaffinization and antigen retrieval, sections were incubated with a rabbit polyclonal anti-EphB2 primary antibody (BOSTER, #A01507–1) at a dilution of 1:200, followed by incubation with a species-specific fluorescently labeled secondary antibody.Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) [6]. ..

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma
    Article Snippet: .. After deparaffinization and antigen retrieval, sections were incubated with a rabbit polyclonal anti-EphB2 primary antibody (BOSTER, #A01507–1) at a dilution of 1:200, followed by incubation with a species-specific fluorescently labeled secondary antibody.Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) [ ]. ..

    Labeling:

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma.
    Article Snippet: .. After deparaffinization and antigen retrieval, sections were incubated with a rabbit polyclonal anti-EphB2 primary antibody (BOSTER, #A01507–1) at a dilution of 1:200, followed by incubation with a species-specific fluorescently labeled secondary antibody.Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) [6]. ..

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma
    Article Snippet: .. After deparaffinization and antigen retrieval, sections were incubated with a rabbit polyclonal anti-EphB2 primary antibody (BOSTER, #A01507–1) at a dilution of 1:200, followed by incubation with a species-specific fluorescently labeled secondary antibody.Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) [ ]. ..



    Similar Products

    rabbit polyclonal anti ephb2 primary antibody  (Boster Bio)
    94
    Boster Bio rabbit polyclonal anti ephb2 primary antibody
    Comparison of serum <t>EphB2</t> levels between NPC patients and the control group. Data are presented as mean ± SD.
    Rabbit Polyclonal Anti Ephb2 Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+ephb2+primary+antibody/Anti-Ephrin+type-B+receptor+2+EPHB2+Antibody/pmc12794068-103-10-15
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti ephb2 primary antibody - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Comparison of serum EphB2 levels between NPC patients and the control group. Data are presented as mean ± SD.

    Journal: Translational Oncology

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma

    doi: 10.1016/j.tranon.2025.102641

    Figure Lengend Snippet: Comparison of serum EphB2 levels between NPC patients and the control group. Data are presented as mean ± SD.

    Article Snippet: After deparaffinization and antigen retrieval, sections were incubated with a rabbit polyclonal anti-EphB2 primary antibody (BOSTER, #A01507–1) at a dilution of 1:200, followed by incubation with a species-specific fluorescently labeled secondary antibody.Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) [ ].

    Techniques: Comparison, Control

    EphB2 protein expression in nasopharyngeal tissues. (A) Representative western blot images of EphB2 expression in control tissues (nasopharyngeal mucosal chronic inflammation) and NPC tissues stratified by clinical stage (I–II vs. III–IV), EBV status, and recurrence status ( n = 3 per subgroup). Approximate molecular weights: EphB2, 117 kDa; GAPDH, 36 kDa. (B) Quantitative analysis of EphB2 expression normalized to GAPDH. Data represent mean ± SD from six independent experiments. ** P < 0.01 by one-way ANOVA with Tukey’s post-hoc test.

    Journal: Translational Oncology

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma

    doi: 10.1016/j.tranon.2025.102641

    Figure Lengend Snippet: EphB2 protein expression in nasopharyngeal tissues. (A) Representative western blot images of EphB2 expression in control tissues (nasopharyngeal mucosal chronic inflammation) and NPC tissues stratified by clinical stage (I–II vs. III–IV), EBV status, and recurrence status ( n = 3 per subgroup). Approximate molecular weights: EphB2, 117 kDa; GAPDH, 36 kDa. (B) Quantitative analysis of EphB2 expression normalized to GAPDH. Data represent mean ± SD from six independent experiments. ** P < 0.01 by one-way ANOVA with Tukey’s post-hoc test.

    Article Snippet: After deparaffinization and antigen retrieval, sections were incubated with a rabbit polyclonal anti-EphB2 primary antibody (BOSTER, #A01507–1) at a dilution of 1:200, followed by incubation with a species-specific fluorescently labeled secondary antibody.Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) [ ].

    Techniques: Expressing, Western Blot, Control

    Immunofluorescence analysis of EphB2 expression in nasopharyngeal tissues. A: Nasopharyngeal mucosal chronic inflammation tissues; B: EBV(-) NPC tissues; C: EBV(+) NPC tissues. EphB2 staining is shown in red; nuclei are counterstained with DAPI (blue). Original magnification: 400×.

    Journal: Translational Oncology

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma

    doi: 10.1016/j.tranon.2025.102641

    Figure Lengend Snippet: Immunofluorescence analysis of EphB2 expression in nasopharyngeal tissues. A: Nasopharyngeal mucosal chronic inflammation tissues; B: EBV(-) NPC tissues; C: EBV(+) NPC tissues. EphB2 staining is shown in red; nuclei are counterstained with DAPI (blue). Original magnification: 400×.

    Article Snippet: After deparaffinization and antigen retrieval, sections were incubated with a rabbit polyclonal anti-EphB2 primary antibody (BOSTER, #A01507–1) at a dilution of 1:200, followed by incubation with a species-specific fluorescently labeled secondary antibody.Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) [ ].

    Techniques: Immunofluorescence, Expressing, Staining

    Disease-free survival analysis based on recurrence (A), EBV infection status (B), and serum EphB2 expression (C). In (C), patients were divided into EphB2-Low and EphB2-High groups using the median serum concentration (11.161 ng/mL) as the cutoff. Vertical ticks indicate censored data.

    Journal: Translational Oncology

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma

    doi: 10.1016/j.tranon.2025.102641

    Figure Lengend Snippet: Disease-free survival analysis based on recurrence (A), EBV infection status (B), and serum EphB2 expression (C). In (C), patients were divided into EphB2-Low and EphB2-High groups using the median serum concentration (11.161 ng/mL) as the cutoff. Vertical ticks indicate censored data.

    Article Snippet: After deparaffinization and antigen retrieval, sections were incubated with a rabbit polyclonal anti-EphB2 primary antibody (BOSTER, #A01507–1) at a dilution of 1:200, followed by incubation with a species-specific fluorescently labeled secondary antibody.Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) [ ].

    Techniques: Infection, Expressing, Concentration Assay

    ROC curves evaluating the diagnostic performance of serum EphB2, EBV infection status, and their combination in discriminating NPC patients from controls.

    Journal: Translational Oncology

    Article Title: Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma

    doi: 10.1016/j.tranon.2025.102641

    Figure Lengend Snippet: ROC curves evaluating the diagnostic performance of serum EphB2, EBV infection status, and their combination in discriminating NPC patients from controls.

    Article Snippet: After deparaffinization and antigen retrieval, sections were incubated with a rabbit polyclonal anti-EphB2 primary antibody (BOSTER, #A01507–1) at a dilution of 1:200, followed by incubation with a species-specific fluorescently labeled secondary antibody.Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) [ ].

    Techniques: Diagnostic Assay, Infection